Which item is NOT typically monitored with lithium therapy?

• A. Thyroid function
• B. Renal function
• C. Serum lipid panel
• D. Serum lithium level

Answer: (C)

When monitoring lithium therapy, the focus is on preventing toxicity and catching known organ effects. Lithium is cleared by the kidneys, so checking renal function (creatinine, BUN, electrolyte status) is essential to ensure the kidneys are handling the drug. It also commonly affects the thyroid, so thyroid function tests (TSH, free T4) are routinely done to catch any lithium-induced hypothyroidism. Keeping track of the actual lithium level in the blood is crucial to stay within the therapeutic range and avoid toxicity.

The serum lipid panel is not typically part of routine lithium monitoring because lithium does not directly influence lipid metabolism and lipid values don’t guide dosing or safety for this medication. Lipids might be checked for general cardiovascular risk in a patient’s broader care, but it’s not a standard, lithium-specific monitoring parameter.